An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening

Biao Wang; Bang-Shun He; Xiao-Lan Ruan; Jiang Zhu; Rui Hu; Jie Wang; Ying Li; Yun-Huang Yang; Mai-Li Liu

doi:10.1186/s40779-022-00409-9

Your Location：

Home >

Browse articles >

An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening

RESEARCH | Updated：2023-07-21

- An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening
- An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening
- MMR 2023年10卷第3期页码：325-341
- Affiliations：
  
  1.Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and Technology-Wuhan National Laboratory for Optoelectronics, Chinese Academy of Sciences, Wuhan 430071, China
  2.Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China
  3.Department of Hematology, Renmin Hospital, Wuhan University, Wuhan 430060, China
  4.University of Chinese Academy of Sciences, Beijing 10049, China
  5.Canary Center at Stanford for Cancer Early Detection, Department of Radiology, School of Medicine, Stanford University, Palo Alto, CA 94304, USA
- Author bio：
  
  * bhe@njmu.edu.cn;
  liying@wipm.ac.cn
- Funds：
  
  This study was funded by the National Natural Science Foundation of China(21904139)
- DOI：10.1186/s40779-022-00409-9
  中图分类号：
- 纸质出版：2023-06
- Accepted：
Scan QR Code
An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening[J]. MMR, 2023,10(3):325-341.

Cite this article as: Wang B, He BS, Ruan XL, Zhu J, Hu R, Wang J, et al. An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening. Mil Med Res. 2022;9(1):51.
An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening[J]. MMR, 2023,10(3):325-341. DOI： 10.1186/s40779-022-00409-9.

Cite this article as: Wang B, He BS, Ruan XL, Zhu J, Hu R, Wang J, et al. An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening. Mil Med Res. 2022;9(1):51. DOI： 10.1186/s40779-022-00409-9.

摘要

Abstract

Background:

Tumor cell heterogeneity mediated drug resistance has been recognized as the stumbling block of cancer treatment. Elucidating the cytotoxicity of anticancer drugs at single-cell level in a high-throughput way is thus of great value for developing precision therapy. However

current techniques suffer from limitations in dynamically characterizing the responses of thousands of single cells or cell clones presented to multiple drug conditions.

Methods:

We developed a new microfluidics-based "SMART" platform that is Simple to operate

able to generate a Massive single-cell array and Multiplex drug concentrations

capable of keeping cells Alive

Retainable and Trackable in the microchambers. These features are achieved by integrating a Microfluidic chamber Array (4320 units) and a six-Concentration gradient generator (MAC)

which enables highly efficient analysis of leukemia drug effects on single cells and cell clones in a high-throughput way.

Results:

A simple procedure produces 6 on-chip drug gradients to treat more than 3000 single cells or single-cell derived clones and thus allows an efficient and precise analysis of cell heterogeneity. The statistic results reveal that Imatinib (Ima) and Resveratrol (Res) combination treatment on single cells or clones is much more efficient than Ima or Res single drug treatment

indicated by the markedly reduced half maximal inhibitory concentration (IC

). Additionally

single-cell derived clones demonstrate a higher IC

in each drug treatment compared to single cells. Moreover

primary cells isolated from two leukemia patients are also found with apparent heterogeneity upon drug treatment on MAC.

Conclusions:

This microfluidics-based "SMART" platform allows high-throughput single-cell capture and culture

dynamic drug-gradient treatment and cell response monitoring

which represents a new approach to efficiently investigate anticancer drug effects and should benefit drug discovery for leukemia and other cancers.

关键词

Keywords

references

Soverini S , Hochhaus A , Nicolini FE , Gruber F , Lange T , Saglio G , et al . BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet . Blood . 2011 ; 118 ( 5 ): 1208 - 15 .

Shen S , Chen X , Cai J , Yu J , Gao J , Hu S , et al . Effect of dasatinib vs imatinib in the treatment of pediatric philadelphia chromosome–positive acute lymphoblastic leukemia: a randomized clinical trial . JAMA Oncol . 2020 ; 6 ( 3 ): 358 - 66 .

Peretz CAC , McGary LHF , Kumar TF , Jackson JH , Jacob J , Durruthy-Durruthy R , Zhang C , et al . Single cell sequencing reveals evolution of tumor heterogeneity of acute myeloid leukemia on quizartinib . Blood . 2019 ; 134 ( Suppl 1 ): 1440 .

Yanagisawa B , Ghiaur G , Smith BD , Jones RJ . Translating leukemia stem cells into the clinical setting: harmonizing the heterogeneity . Exp Hematol . 2016 ; 44 ( 12 ): 1130 - 7 .

Akbarzadeh M , Maroufi NF , Tazehkand AP , Akbarzadeh M , Bastani S , Safdari R , et al . Current approaches in identification and isolation of cancer stem cells . J Cell Physiol . 2019 ; 234 ( 9 ): 14759 - 72 .

Macaulay IC , Ponting CP , Voet T . Single-cell multiomics: multiple measurements from single cells . Trends Genet . 2017 ; 33 ( 2 ): 155 - 68 .

Yellen BB , Zawistowski JS , Czech EA , Sanford CI , SoRelle ED , Luftig MA , et al . Massively parallel quantification of phenotypic heterogeneity in single-cell drug responses . Sci Adv . 2021 ; 7 ( 38 ): eabf9840 .

Gao D , Jin F , Zhou M , Jiang Y . Recent advances in single cell manipulation and biochemical analysis on microfluidics . Analyst . 2019 ; 144 ( 3 ): 766 - 81 .

Zhang P , Shao N , Qin L . Recent advances in microfluidic platforms for programming cell-based living materials . Adv Mater . 2021 ; 33 ( 46 ): e2005944 .

Li Y , Jang JH , Wang C , He B , Zhang K , Zhang P , et al . Microfluidics cell loading-dock system: Ordered cellular array for dynamic lymphocytecommunication study . Adv Biosyst . 2017 ; 1 ( 10 ): e1700085 .

Pang L , Ding J , Liu XX , Yuan H , Ge Y , Fan J , et al . Microstructure-based techniques for single-cell manipulation and analysis . TRAC-Trend Anal Chem . 2020 ; 129 : 115940 .

Chen Y , Song J , Ruan Q , Zeng X , Wu L , Cai L , et al . Single-cell sequencing methodologies: from transcriptome to multi-dimensional measurement . Small Methods . 2021 ; 5 ( 6 ): e2100111 .

Zhang FJ , Liu HB , Gao MQ , Wang DF , Niu YB , Shen SF . Concentration-gradient microfluidic chips for drug screening . Prog Chem . 2021 ; 33 ( 7 ): 1238 - 51 .

Li L , Li Y , Shao Z , Luo G , Ding M , Liang Q . Simultaneous assay of oxygen-dependent cytotoxicity and genotoxicity of anticancer drugs on an integrated microchip . Anal Chem . 2018 ; 90 ( 20 ): 11899 - 907 .

Garcia-Hernando M , Calatayud-Sanchez A , Etxebarria-Elezgarai J , de Pancorbo MM , Benito-Lopez F , Basabe-Desmonts L . Optical single cell resolution cytotoxicity biosensor based on single cell adhesion dot arrays . Anal Chem . 2020 ; 92 ( 14 ): 9658 - 65 .

Lin D , Li P , Feng J , Lin Z , Chen X , Yang N , et al . Screening therapeutic agents specific to breast cancer stem cells using a microfluidic single-cell clone-forming inhibition assay . Small . 2020 ; 16 ( 9 ): e1901001 .

Chen P , Chen D , Li S , Ou X , Liu BF . Microfluidics towards single cell resolution protein analysis . TRAC-Trend Anal Chem . 2019 ; 117 : 2 - 12 .

Pang L , Liu W , Tian C , Xu J , Li T , Chen SW , et al . Construction of single-cell arrays and assay of cell drug resistance in an integrated microfluidic platform . Lab Chip . 2016 ; 16 ( 23 ): 4612 - 20 .

Pang L , Ding J , Ge Y , Fan J , Fan SK . Single-cell-derived tumor-sphere formation and drug-resistance assay using an integrated microfluidics . Anal Chem . 2019 ; 91 ( 13 ): 8318 - 25 .

Strydom N , Gupta SV , Fox WS , Via LE , Bang H , Lee M , et al . Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization . PLoS Med . 2019 ; 16 ( 4 ): e1002773 .

Liu X , Jia Y , Han Z , Hou Q , Zhang W , Zheng W , et al . Integrating a concentration gradient generator and a single-cell trapper array for high-throughput screening the bioeffects of nanomaterials . Angew Chem Int Ed Engl . 2021 ; 60 ( 22 ): 12319 - 22 .

Pei H , Yu M , Dong D , Wang Y , Li Q , Li L , et al . Phenotype-related drug sensitivity analysis of single CTCs for medicine evaluation . Chem Sci . 2020 ; 11 ( 33 ): 8895 - 900 .

Zhao SK , Hu XJ , Zhu JM , Luo ZY , Liang L , Yang DY , et al . On-chip rapid drug screening of leukemia cells by acoustic streaming . Lab Chip . 2021 ; 21 ( 20 ): 4005 - 15 .

Li Y , Zhang P , Li T , Hu R , Zhu J , He T , et al . A virtual-droplet system for sensing MMP9 activity of single suspended and adhered cancer cells . Sensor Actuat B-Chem . 2020 ; 308 : 127749 .

Deininger M , Buchdunger E , Druker BJ , Deininger M , Buchdunger E , Druker BJ . The development of imatinib as a therapeutic agent for chronic myeloid leukemia . Blood . 2005 ; 105 ( 7 ): 2640 - 53 .

Meng X , Zhou J , Zhao CN , Gan RY , Li HB . Health benefits and molecular mechanisms of resveratrol: a narrative review . Foods . 2020 ; 9 ( 3 ): 340 .

Bachas C , Schuurhuis GJ , Assaraf YG , Kwidama ZJ , Kelder A , Wouters F , et al . The role of minor subpopulations within the leukemic blast compartment of AML patients at initial diagnosis in the development of relapse . Leukemia . 2012 ; 26 ( 6 ): 1313 - 20 .

Murphy T , Yee KWL . Cytarabine and daunorubicin for the treatment of acute myeloid leukemia . Expert Opin Pharmacother . 2017 ; 18 ( 16 ): 1765 - 80 .

Tardi P , Johnstone S , Harasyrn N , Xie S , Harasyrn T , Zisman N , et al . In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy . Leuk Res . 2009 ; 33 ( 1 ): 129 - 39 .

Li Y , Motschman JD , Kelly ST , Yellen BB . Injection molded microfluidics for establishing high-density single cell arrays in an open hydrogel format . Anal Chem . 2020 ; 92 ( 3 ): 2794 - 801 .

Duarte-Sanmiguel S , Shukla V , Benner B , Moore J , Lemmerman L , Lawrence W , et al . Guided migration analyses at the single-clone level uncover cellular targets of interest in tumor-associated myeloid-derived suppressor cell populations . Sci Rep . 2020 ; 10 ( 1 ): 1189 .

Klein E , Benbassat H , Neumann H , Ralph P , Zeuthen J , Polliack A , et al . Properties of K562 cell line, derived from a patient with chronic myeloid leukemia . Int J Cancer . 1976 ; 18 ( 4 ): 421 - 31 .

Voss J , Posern G , Hannemann JR , Wiedemann LM , Turhan AG , Poirel H , et al . The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways . Oncogene . 2000 ; 19 ( 13 ): 1684 - 90 .

Can G , Cakir Z , Kartal M , Gunduz U , Baran Y . Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells . Anticancer Res . 2012 ; 32 ( 7 ): 2673 - 8 .

Yano S , Takehara K , Tazawa H , Kishimoto H , Urata Y , Kagawa S , et al . Cellcycle-dependent drug-resistant quiescent cancer cells induce tumor angiogenesis after chemotherapy as visualized by real-time FUCCI imaging . Cell Cycle . 2017 ; 16 ( 5 ): 406 - 14 .

Bach DH , Hong JY , Park HJ , Lee SK . The role of exosomes and miRNAs in drug-resistance of cancer cells . Int J Cancer . 2017 ; 141 ( 2 ): 220 - 30 .

Guo L , Dial S , Shi L , Branham W , Liu J , Fang JL , et al . Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes . Drug Metab Dispos . 2011 ; 39 ( 3 ): 528 - 38 .

Novakovic B , Gordon L , Wong NC , Moffett A , Manuelpillai U , Craig JM , et al . Wide-ranging DNA methylation differences of primary trophoblast cell populations and derived cell lines: implications and opportunities for understanding trophoblast function . Mol Hum Reprod . 2011 ; 17 ( 6 ): 344 - 53 .

Mebarki M , Bennaceur A , Bonhomme-Faivre L . Human-cell-derived organoids as a new ex vivo model for drug assays in oncology . Drug Discov Today . 2018 ; 23 ( 4 ): 857 - 63 .

Tian F , Han Z , Deng J , Liu C , Sun J . Thermomicrofluidics for biosensing applications . View . 2021 ; 2 ( 6 ): 20200148 .

Gorman BR , Wikswo JP . Characterization of transport in microfluidic gradient generators . Microfluid Nanofluid . 2008 ; 4 : 273 .

Guo H , Qian L , Cui J . Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome . Cancer Biol Med . 2021 ; 19 ( 3 ): 333 - 42 .

Stuart T , Satija R . Integrative single-cell analysis . Nat Rev Genet . 2019 ; 20 ( 5 ): 257 - 72 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Single-cell transcriptome profiling of sepsis identifies HLA-DR^lowS100A^high monocytes with immunosuppressive function

Microfluidics-based strategies for molecular diagnostics of infectious diseases

芜湖长江大桥裕溪河桥车桥耦合振动分析

摆式列车线路检测信号的动态自适应滤波研究

地铁高架槽形梁足尺模型破坏试验与空间分析研究